SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-20-008101
Filing Date
2020-05-08
Accepted
2020-05-08 17:14:12
Documents
1
Period of Report
2020-05-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3366
  Complete submission text file 0001493152-20-008101.txt   5000
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Issuer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6144 HAGERSTOWN DRIVE BATON ROUGE LA 70817
Business Address
HEAD JONATHAN FREDERICK (Reporting) CIK: 0001653951 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52218 | Film No.: 20861715